Turn this role into an interview — a resume and cover letter built around what this employer wants.
The University of Bradford invites applications for a Research Associate in the Institute of Health and Social Care, within the Institute of Cancer Therapeutics. The role focuses on evaluating hypoxia-selective therapeutics using cancer models and supporting translational drug development.
You will apply molecular biology methods including flow cytometry and LC-MS analyses to study drug activation, stability and pharmacokinetics, contributing to data analysis and dissemination of findings.
View All Opportunities
Research Associate
Institute of Health and Social Care
Pharmaceutical Sciences (including ICT and CPSS)
Salary: £35,608 to £38,784 per annum Fixed Term for 12 months Post Type: Full Time Contract Type: Fixed Term Closing Date: Wednesday 21 October 2026 Interview Date: To be confirmed Reference: HR0204544-1
University of Bradford
At the University of Bradford, our focus is on creating the conditions for social, cultural, and economic impact. We are committed to social inclusion. Our work to expand opportunity and enable students to reach their potential, has led to us topping the Social Mobility Index of English universities for the last five years. Our University Strategy sets out our ambitions for 2027, which we will achieve by using our proud heritage as a springboard and remaining steadfast in our commitment to equality, diversity, and inclusion.
Safeguarding
The University of Bradford is committed to safeguarding, protecting and promoting the welfare of children, young people, and Adults at Risk through robust safer recruitment practices. An enhanced DBS check is required for this role.
Faculty
The Institute of Cancer Therapeutics (ICT), within the Institute of Health and Social Care, has over 30 years of internationally recognised expertise in cancer pharmacology, drug discovery and translational research. Its multidisciplinary and collaborative environment reflects the University’s values of excellence, innovation, inclusion and impact, with a strong focus on translating scientific discoveries into improved cancer treatments.
What You Will Be Doing